You can apply an excellent serum and still have most of it sit on the surface of your skin. The outermost layer — the stratum corneum — evolved specifically to keep things out, and it is very good at its job. Iontophoresis uses a gentle electrical current to help charged skincare actives cross that barrier more effectively than they would on their own.
It is one of the older technologies in this category, well established in both dermatology and cosmetic science, and it is unusual among at-home skincare tech in that its core claim — improved penetration — is measurable in a laboratory rather than only inferred.
How it works ?
The barrier problem. The stratum corneum is a dense, lipid-rich layer that blocks most water-soluble molecules. Vitamin C in its active form (L-ascorbic acid) is a good example: it is highly effective in principle, but it is water-soluble and negatively charged at typical formulation pH, which makes passive absorption inefficient. Much of what you apply never reaches the living tissue below.
Two physical mechanisms. Iontophoresis applies a mild direct current through two electrodes, driving delivery in two ways:
Electrorepulsion is the primary mechanism. Like charges repel. If you place a negatively charged active under a negatively charged electrode, the electrode pushes the molecules away from itself — which means into the skin. This is why polarity matters: the active must be paired with the matching electrode, or the current will work against you rather than for you.
Electro-osmosis is a secondary effect. The current also causes bulk fluid movement through the skin, which carries dissolved molecules along with it. This assists neutral and larger molecules that electrorepulsion alone would not move.
Why it suits some ingredients and not others. Iontophoresis works best with small, water-soluble, ionisable molecules. Vitamin C, niacinamide, hyaluronic acid (in low-molecular-weight forms) and various peptides are plausible candidates. Oil-soluble ingredients and heavy occlusive formulations are poor candidates — oils actively block conduction. This is why "use it with any serum" is inaccurate advice.
What the research shows
Human split-face trial with a handheld device. Yan et al. (Journal of Cosmetic Dermatology 2022) ran a prospective split-face trial in 24 subjects with photoaged skin, treating the left side with a handheld iontophoresis device twice weekly for eight weeks, with assessments at baseline and at 2, 4, 6 and 8 weeks. Primary outcomes were pore tightening and skin hydration, and the treated side showed significant improvement in pore tightening at both the 2-week and 8-week follow-ups (p = 0.019 and p = 0.026). The authors concluded the device is safe and can serve as an adjunctive home treatment for enhancing transdermal vitamin C delivery. Notably, this used a consumer-style handheld device, not clinic equipment.
Randomised, placebo-controlled melasma trial. Huh et al. (Dermatology 2003) enrolled 29 women with melasma in a double-blind, placebo-controlled split-face design: vitamin C solution with iontophoresis on one side, distilled water on the other. At 12 weeks the treated side showed a significant reduction in the colorimeter L-value (4.60 → 2.78, p = 0.002), while the control side did not reach significance (4.45 → 3.87, p = 0.142). The direct within-person comparison makes this a useful design despite the modest size.
Review-level evidence. Liatsopoulou et al. (International Journal of Cosmetic Science 2023) surveyed iontophoresis across dermato-cosmetic applications and concluded it can be safely and successfully used for ageing, photoageing, hyperpigmentation and oxidative stress. The review documents cases with mean improvements of 73%, 62% and 39% in abnormal pigmentation, skin texture and wrinkles respectively, as scored by four independent observers. It also usefully reframes the terminology: because cosmetic actives are intended to act locally rather than systemically, "dermal delivery" is more accurate than "transdermal delivery" in this context.
Laboratory permeation data. Controlled diffusion-cell studies consistently show measurable penetration increases. In one representative comparison, iontophoresis raised skin permeation of (+)-catechin roughly 3.7-fold versus passive application (5.13 ± 1.36 vs 1.40 ± 0.32, p < 0.05). A 2025 review in Expert Opinion on Drug Delivery analysing the 2024 literature confirms the mechanism is well characterised, while noting that the lack of standardised protocols remains a barrier to consistent real-world results.
Honest limitations
Better delivery is not the same as better results. This is the central honest point. Iontophoresis reliably improves how much of an active gets in — that part is well supported. Whether that translates into a visible cosmetic difference depends entirely on whether the active itself works, at what concentration, and for what concern. The technology is a delivery amplifier, not an effect in itself.
Protocols are not standardised. Current intensity, duration, formulation pH and electrode polarity all materially affect outcomes, and there is no agreed consumer standard. Two devices with identical marketing may perform very differently. Reviews explicitly flag this as the field's main weakness.
Studies are small and short. The trials above enrolled 24 and 29 participants over 8 and 12 weeks respectively. That is typical for cosmetic research but means results should be read as indicative.
Confounders exist. The melasma trial's authors noted that sunscreen was applied to both sides, which may have influenced outcomes — a reminder that pigmentation results always depend heavily on sun protection.
It does not turn a cosmetic into a medicine. Enhanced delivery of a cosmetic ingredient is still cosmetic. Iontophoresis does not give a serum drug-level effects, and any claim in that direction should be treated sceptically.
Formulation compatibility is a real constraint. If your serum is oil-based, heavily silicone-based, or contains large molecules, iontophoresis will do little. The device cannot compensate for an incompatible product.
Using it safely
Choose the right product. Use a thin, water-based, ionisable serum — vitamin C is the classic pairing. Avoid oils, balms, heavy creams and silicone-rich textures during the session. Apply your richer products afterwards.
Get the polarity right. This is the step most people miss. Most devices have a negative (−) and positive (+) mode. Negatively charged actives such as L-ascorbic acid are driven in using the negative setting. Check your device's manual and your serum's charge; using the wrong polarity can pull the active back out rather than in.
Technique. Work on clean, damp skin in small sections, moving slowly and keeping the electrode in contact. If the serum dries out, reapply — dry skin breaks the circuit. Sessions are typically short, in the range of several minutes per area.
Frequency. Twice weekly matches the protocol used in the clinical trial above. Daily use is not required, and with active ingredients like vitamin C, more frequent enhanced delivery can increase irritation risk.
Sun protection is non-negotiable. If you are using iontophoresis for pigmentation or photoageing, daily broad-spectrum sunscreen determines whether you see results at all.
Who should avoid it. Do not use if you have a pacemaker or other implanted electronic device, if you have epilepsy, or if you are pregnant. Avoid over broken, irritated or inflamed skin, over metal implants in the treatment area, and immediately after exfoliating treatments, when penetration enhancement could cause irritation.
Frequently asked questions
Does iontophoresis actually make serums work better?
It reliably increases how much active enters the skin, and that is well documented in laboratory and clinical work. Whether you see a visible difference depends on the serum itself — the device amplifies an active's delivery, it does not create an effect on its own.
What serums work best with iontophoresis?
Thin, water-based, ionisable formulations. Vitamin C (L-ascorbic acid) is the best-studied. Niacinamide, low-molecular-weight hyaluronic acid and some peptides are also plausible. Oil-based and heavy occlusive products do not work — they block conduction.
Which polarity should I use?
It depends on the active's charge. Negatively charged actives like L-ascorbic acid pair with the negative setting. Consult your device manual; incorrect polarity can reduce delivery rather than improve it.
How often should I use it?
Around twice weekly matches the published clinical protocol. Daily use is unnecessary and may increase irritation, particularly with vitamin C.
Is iontophoresis the same as a galvanic facial?
They are closely related — both use direct current for skin applications. "Galvanic" is the older salon term and sometimes describes a two-phase protocol (a cleansing phase followed by an infusing phase). The infusing phase is essentially iontophoresis.
Can I feel anything during treatment?
Usually a mild tingling or metallic taste sensation. It should never sting or burn. Discomfort typically means the current is too high or the skin has dried out.
Can I use it after a peel or exfoliation?
No. Enhanced penetration on a compromised barrier is a recipe for irritation. Wait until the skin has fully recovered.
Will it help with melasma or dark spots?
The randomised evidence for vitamin C iontophoresis in melasma is encouraging but comes from small trials, and pigmentation results depend heavily on rigorous daily sun protection. Treat it as supportive rather than a solution.